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Background: Quercetin has been shown to induce apoptosis in a number of cancer cell lines, 
but a quercetin-loaded nanoliposomal formulation with enhanced antitumor activity in C6 glioma 
cells and its effect on cancer cell death has not been well studied. The aim of this study was to 
examine if quercetin-loaded liposomes (QUE-NL) has enhanced cytotoxic effects and if such 
effects involve type III programmed cell death in C6 glioma cells.
Methods: C6 glioma cells were treated with QUE-NL and assayed for cell survival, apoptosis, 
and necrosis. Levels of reactive oxygen species production and loss of mitochondrial membrane 
potential (∆Ψm) were also determined by flow cytometry assay to assess the effects of QUE-NL. 
ATP levels and lactate dehydrogenase activity were measured, and Western blotting was used 
to assay cytochrome C release and caspase expression.
Results: QUE-NL induced type III (necrotic) programmed cell death in C6 glioma cells in 
a dose-dependent and time-dependent manner. High concentrations of QUE-NL induced cell 
necrosis, which is distinct from apoptosis and autophagy, whereas liposomes administered 
alone induced neither significant apoptosis nor necrosis in C6 glioma cells. QUE-NL-induced 
∆Ψm loss and cytochrome C release had no effect on caspase activation, but decreased ATP 
levels and increased lactate dehydrogenase activity indicated that QUE-NL stimulated necrotic 
cell death.
Conclusion: C6 glioma cells treated with QUE-NL showed a cellular pattern associated 
with necrosis without apoptosis and was independent of caspase activity. Nonapoptotic cell 
death induced by high concentrations of QUE-NL for controlling caspase-independent type III 
programmed cell death may provide the basis for novel therapeutic approaches to overcome 
avoidance of apoptosis by malignant cells.
Keywords: quercetin, liposome, type III programmed cell death, reactive oxygen species, ATP, 
mitochondria, C6 glioma cells
Introduction
Programmed cell death can be divided into three different morphological and 
biochemical categories, ie, type I, type II, and type III.1,2 Type I programmed cell 
death consists of classical apoptotic cell death, characterized by cellular shrinkage, 
chromatin condensation, and DNA degradation. Apoptotic programmed cell death 
is a highly regulated process associated with several molecular events involving 
receptors, proapoptotic/antiapoptotic proteins, and signaling pathways mediated by 
caspases and/or the mitochondrial apoptogenic protein cytochrome c, Omi/HtrA2, 
or Smac/DIABLO3, leading to DNA fragmentation and eventually cell death.3 
Type II (autophagic) programmed cell death is characterized by engulfment of cellular 
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organelles  such  as  mitochondria  and  endoplasmic 
reticulum by cytoplasmic vesicles, and seems to involve 
lysosomal cathepsins.2,4
Type III (necrosis-like) programmed cell death is defined 
exclusively by cytoplasmic features.1,4 Unfortunately, the 
pathways implicated in this last type of programmed cell 
death are poorly understood. In any case, type III programmed 
cell death seems to operate in a caspase-independent 
manner.3 Furthermore, necrosis is usually triggered by 
pathophysiological conditions, such as inflammation, 
infection, or ischemia.5 Nonapoptotic machinery or necrotic 
cell death may be useful in cancer therapy, and this previously 
unknown mechanism controlling caspase-independent 
type III programmed cell death may provide the basis 
for novel therapeutic approaches to overcome apoptotic 
avoidance in malignant cells.
Gliomas are the most frequent primary tumors   occurring 
in the central nervous system, patients with malignant 
glioma have a very poor prognosis, and cure rates are not 
satisfactory.6 Unfortunately, during progression towards 
drug-resistant disease, the apoptotic machinery, consisting 
of antiapoptotic and proapoptotic proteins, is not balanced 
and often favors cell survival following cytotoxic insult. 
In such a scenario, agents that initiate nonapoptotic cell 
death may   easily overcome inherent deficiencies in the 
apoptotic machinery of cancer cells. Currently, investigators 
are focused on new agents and novel targets for treatment 
of glioma.
Quercetin has a wide range of biological activity, including 
inhibition of mutant p53 expression,7 and it enhances 
apoptosis mediated by death receptors in glioma cells.8 
Quercetin-mediated apoptosis may result from induction of 
stress proteins, including the heat shock proteins, disruption 
of microtubules, mitochondrial release of cytochrome c, and 
activation of caspases.9–11 These activities of quercetin make 
it a promising candidate for treatment and prevention of 
various cancers. However, insolubility of quercetin in water 
results in poor absorption, low bioavailability, and inability 
to cross the blood–brain barrier, thereby limiting its potential 
clinical application in the treatment of cancer. Furthermore, 
the solvent used, eg, dimethylsulfoxide, may cause hemolysis 
and liver and kidney damage. Therefore, development of 
novel preparations that enhance the solubility of quercetin 
and improve its bioactivity in inhibiting tumor growth is 
of great importance. The research objective in this study 
was to prepare quercetin nanoliposomes (QUE-NL) using 
the emulsification-evaporation and low temperature curing 
method. In the present study, we show that high QUE-NL 
concentrations can induce a type of cell death which is 
distinct from apoptosis and autophagy, induces necrotic but 
not apoptotic cell death, and is associated with loss of the 
mitochondrial membrane potential (∆Ψm) and induction of 
reactive oxygen species. Because most current anticancer 
drugs signal through the mitochondria, we speculated 
that QUE-NL might be an alternative target for induction 
of tumor cell death. In this report, we demonstrate that 
QUE-NL-induced necrotic cell death was partially reversible 
by pretreatment with N-acetylcysteine, an antioxidant. 
Understanding the mechanisms linking the oxidative-
induced necrosis response in cell death pathways could 
suggest new therapeutic strategies for treatment of oxidative 
stress-associated diseases. In this work, we investigated the 
mechanisms that govern the reciprocal regulation of necrosis 
and death pathways in C6 glioma cells. There are no reports 
addressing the effects of QUE-NL on necrosis in C6 glioma 
cells, so the aim of this study was to determine if QUE-NL 
was cytotoxic to C6 glioma cells and to assess the role of 
QUE-NL-induced necrosis in cell death.
Materials and methods
Chemicals and reagents
Propidium iodide and N-acetylcysteine were obtained from 
Sigma Chemical Co (St Louis, MO). DCFH-DA, DiOC6(3), 
and Indo 1/AM were purchased from Molecular Probes 
(BestBio Biotechnologies, Shanghai, China). Roswell 
Park Memorial Institute (RPMI) 1640 medium, penicillin-
streptomycin, trypsin-ethylenediamine tetra-acetic acid, fetal 
bovine serum, and L-glutamine were obtained from Gibco 
(Invitrogen, Carlsbad, CA). A mitochondrial membrane 
potential assay kit with JC-1 was obtained from BestBio 
Biotechnologies, along with a caspase-3 activity assay kit, an 
ATP detection kit, and a lactate dehydrogenase cytotoxicity 
assay kit. Cytochrome c, caspase-3 and caspase-9 antibodies 
were obtained from Santa Cruz Biotechnology (Santa 
Cruz, CA).
Preparation of QUE-NL
QUE-NLs were prepared using the emulsification-evaporation 
and low temperature curing method.12 The aqueous phase 
comprised Poloxamer 188, PEG2000-DPSE, and Tween 80 
(1:1:1, w/w/v) dissolved in pure water and maintained in a water 
bath at 75°C. The oil phase was composed mainly of glyceryl 
behenate, soy lecithin, and cholesterol (1:2:1, w/w/w); the 
glyceryl behenate and cholesterol were melted in a water bath 
at 80°C. Quercetin 1% (w/v) and soy lecithin were dissolved 
in an ethanol-acetone mixed solvent (1:1, v/v) to obtain a   
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weight ratio of lecithin to quercetin of 10:1. Quercetin and 
soy lecithin were then dissolved in the oil phase, and then 
the oil phase of the aforementioned mixed solvent was 
injected into the aqueous phase through plastic needle tubing 
(internal diameter 0.45 µm, injection rate 2 mL/minute) under 
mechanical agitation at 1000 rpm. After stirring for 2 hours, 
the liposome suspension was cured at a low temperature of 
-4°C. The QUE-NL system was obtained after the resulting 
suspension was filtered through a filter membrane (0.2 µm) to 
remove the nonincorporated drug. Liposomes containing no 
quercetin were also prepared in the same manner as described 
above. Before use in this experiment, QUE-NL were well 
distributed in RPMI 1640 medium containing 10% (v/v) 
heat-activated fetal bovine serum, using ultrasound in order 
to obtain a QUE-NL suspension.
Characteristics of QUE-NL
To observe the particle size and morphology of the QUE-NL 
(Figure 1), the sample was dispersed in deionized water and 
measured using a JEM-2100 transmission electron micro-
scope (JEOL, Tokyo, Japan).
Cell culture and treatment
The C6 glioma cells were purchased from the American Tissue 
Culture Collection (Rockville, MD). The cells were cultured 
at 37°C with 5% CO2 in a humidified atmosphere using RPMI 
1640 supplemented with 10% fetal bovine serum, penicillin 
100 U/mL, and streptomycin 100 U/mL. Cultured C6 glioma 
cells were treated in vitro with the indicated amounts of 
QUE-NL for up to 12 hours. Different concentrations of 
QUE-NL or quercetin (QUE) and N-acetylcysteine (NAC) 
were added to the cells, respectively, with 1% dimethyl sul-
foxide (DMSO) blank nanoliposomes as the control.
Morphological changes and viability
Different concentrations (0, 50, 100, 200 and 400 µM) of 
QUE-NL or quercetin alone were added to the cells, with 1% 
dimethylsulfoxide as a solvent control. Cells were grown and 
incubated for specified time periods (12, 24, 36, and 48 hours). 
Electron microscopy and morphometric analysis were per-
formed as described previously. Cells were fixed for 30 minutes 
with ice-cold 3% glutaraldehyde in 0.1 M cacodylate buffer, 
embedded in Epon, and processed for transmission electron 
microscopy by standard procedures. Representative areas were 
chosen for ultrathin sectioning and examined by transmission 
electron microscopy at 400× magnification.
Analysis of cell death
Cells were incubated with different concentrations (0, 
50, 100, 200, and 400 µM) of QUE-NL or quercetin for 
12 hours. Cells were then trypsinized and harvested by 
centrifugation before incubation with Annexin V and 
propidium iodide for 15 minutes at room temperature. 
Necrosis was examined and rates were analyzed by flow 
cytometry using an Annexin V-FITC/propidium iodide kit 
(BestBio Biotechnologies). Annexin V binds to necrotic 
and apoptotic cells in which phosphatidylserine is exposed 
on the cell surface and the percentage of necrotic cells 
is determined.13
Reactive oxygen species and ∆Ψm
Cells were incubated with different concentrations (0, 50, 
100, 200, and 400 µM) of QUE-NL or quercetin for 12 hours, 
and changes in reactive oxygen species production and 
∆Ψm were measured. In addition, cells were also pretreated 
with or without the antioxidant N-acetylcysteine 3 hours 
prior to treatment with 200 µM QUE-NL or quercetin to 
examine the effects on reactive oxygen species. Cells were 
harvested, washed twice in phosphate-buffered saline, and 
then resuspended in 500 µL of DCFH-DA 10 µM for mea-
surement of reactive oxygen species levels and DiOC6(3) 
4 µmol/L for measurement of ∆Ψm in a dark room for 
30 minutes at 37°C, and then assayed by flow cytometry as 
previously described.13–15
80
60
40
20
0
25 50 75 100
Particle diameter (nm)
P
a
r
t
i
c
l
e
 
d
i
s
t
r
i
b
u
t
i
o
n
 
(
%
)
125 150 175 200
100
AB
Figure 1 Particle average size and size distribution of quercetin nanoliposomes. Image (A) and mean size (B) of quercetin nanoliposomes.
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Caspase-3 and caspase-9 activity
Cells were treated with QUE-NL or quercetin (200, 400 µM) 
or dimethylsulfoxide alone for 12 hours. Caspase-3 and 
caspase-9 activity and cell viability were determined using 
a caspase-3,9 activity assay kit (10 µM), and then analyzed 
by flow cytometry.16
ATP and lactate dehydrogenase levels
Cells were seeded in 100 µL phenol red-free medium with a 
serial concentration of QUE-NL or quercetin (200 µM) for 
6 hours onto 96-well white microplates, and the intracellular 
ATP content level was measured using a Luminescence 
ATP detection assay kit as described elsewhere.17 The 
resulting luminescence was monitored using a luminometer 
  (SynergyTM HT multimode microplate reader, Bio-Tek, 
Winooski, VT). Necrotic cell death was estimated by deter-
mining the amount of lactate dehydrogenase released into the 
culture medium after 12 hours of incubation with QUE-NL 
or quercetin (200 µM), with dimethylsulfoxide as the sol-
vent control. The amount of lactate dehydrogenase released 
into the phenol red-free medium was determined using a 
lactate dehydrogenase assay kit and procedures described 
by the manufacturer.18
Assay for cytochrome c, caspase-3,  
and caspase-9
For protein analysis, the cells were harvested 12 hours 
following the different treatments as described above, washed 
with cold phosphate-buffered saline, and then incubated 
in ice-cold RIPA buffer. Cell lysates were sonicated for 
30 seconds on ice and then lysed at 4°C for 60 minutes. 
The cell lysates were centrifuged for 30 minutes at 4°C and 
12,000 g. Protein concentrations in the supernatants were 
determined using bicinchoninic acid reagent. Total protein 
was separated by denaturing 8%–12% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis, and resolved 
and electrotransferred by semi-dry blotting (Bio-Rad 
Laboratories, Hercules, CA) onto a nitrocellulose membrane. 
Membranes were incubated with antibodies to caspase-3, 
caspase-9, and β-actin (Santa Cruz Biotechnology).
Results
Characteristics of QUE-NL
The morphology of QUE-NL was observed under transmission 
electron microscopy. As shown in Figure 1, the optimized 
nanoliposomes were spherical. The range of particle size of 
the drug-loaded nanoliposomes was 62.3 nm–191.5 nm. The 
average diameter of the nanoliposomes was 116.7 nm.
Effects of QUE-NL on cell morphology 
and viability
QUE-NL induced morphological changes and cell death as 
shown in Figure 2A. The results demonstrated that QUE-NL 
caused necrotic morphological changes and decreased the 
percentage of viable cells, and that these effects were dose-
dependent and time-dependent, while the experimental group 
treated with liposomes alone showed neither apoptosis nor 
necrosis in C6 glioma cells (Figure 2B). Dimethylsulfoxide 
1% had no significant effect on cell viability in C6 glioma 
cells (Figure 2B).
Effects of QUE-NL on necrotic cell death
QUE-NL induced significant cell apoptosis at concentrations 
of 0, 50, and 100 µM when incubated for 12 hours. However, 
cells exposed to higher concentrations (200 and 400 µM) for 
12 hours showed cell death. Annexin V/propidium iodide 
assay examination indicated that cell death was due to 
necrosis (Figure 3A and B) because an apoptosis population 
was not observed. These data are comparable with data in 
Figure 3 showing that QUE-NL decreased the percentage of 
viable cells and induced necrotic morphological changes.
Effects of QUE-NL on reactive oxygen 
species production and ∆Ψm
To evaluate necrosis of reactive oxygen species induced by 
QUE-NL, C6 glioma cells were treated with N-acetylcysteine, 
which reduced reactive oxygen species effectively. Treatment 
efficacy was estimated by flow cytometry analysis. As 
shown in Figure 4A and C, reactive oxygen species activity 
significantly increased in C6 glioma cells treated with 
QUE-NL alone (Figure 4K). N-acetylcysteine in combination 
with QUE-NL decreased reactive oxygen species levels 
(Figure 4C and D).
To determine whether the mitochondrial pathway is 
involved in induction of cell necrosis by QUE-NL, we 
examined changes in ∆Ψm and release of proapoptotic 
molecules from the mitochondria in response to treatment 
with QUE-NL. As shown in Figure 4G, QUE-NL induced 
significant dissipation of ∆Ψm, indicating that QUE-NL-
induced cell death is accompanied by mitochondrial 
dysfunction. Moreover, N-acetylcysteine markedly inhibited 
QUE-NL-induced ∆Ψm. QUE-NL increased reactive 
oxygen species production and reduced ∆Ψm as shown in 
Figure 4G. N-acetylcysteine decreased QUE-NL-induced 
reactive oxygen species production (Figure 4H and J) and 
the percentage of cell death was decreased by 28.6% in the 
presence of N-acetylcysteine 0.2 mM (Figure 4E).
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Caspase-3 and caspase-9 activity  
and cytochrome c protein levels
It can be seen in Figure 5A and B that QUE-NL had no effect 
on protein levels of caspase-3 and caspase-9 but promoted 
levels of cytochrome c. These results are in agreement with 
other reports.19 Even though cytochrome c is released from 
mitochondria in necrotic cells, due to the decrease in total 
cytochrome c, it cannot interact with caspase-3 and caspase-9 
to form apoptosomes; thus, the caspase cascade could not be 
activated for apoptotic occurrences.
ATP levels, lactate dehydrogenase activity, 
and cell survival
QUE-NL decreased ATP levels (Figure 6A) by around 
76%–94% (P , 0.01 and P , 0.001) but promoted lactate 
dehydrogenase activity (Figure 6B) by about 40%–53% 
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Figure 2 Effects of QUE-NL on cell morphology and percentage of viable C6 glioma cells. (A) Cells were examined and photographed by phase-contrast microscopy (200×) 
for percentage of viable cells. (B) Cells were cultured with various concentrations of QUE-NL for 12, 24, 36, and 48 hours. 
Notes: Each point is mean ± standard deviation of three experiments. *P , 0.05; **P , 0.01; ***P , 0.001, significantly different from the control. 
Abbreviations: QUE, quercetin; QUE-NL, nanoliposomes; DMSO, dimethylsulfoxide.
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(P , 0.05 and P , 0.01). The percentage of viable cells was 
treated with QUE-NL or quercetin (Figure 1).
Discussion
It is well documented that cell death can be divided into 
apoptosis and necrosis.20 Most chemotherapy drugs induce 
apoptosis, but some drugs can cause necrosis.21 Necro-
sis is an irreversible inflammatory form of cell death, 
and it is also known that therapy-induced necrotic cell 
death initiates an immune response to tumor cells. How-
ever, whether or not the inflammation is associated with 
necrosis is still unclear, but therapeutic agents that target 
Figure 3 Apoptosis and necrosis in C6 glioma cells induced by QUE-NL. Cells were treated with the indicated concentration of nanoliposome of quercetin (QUE-NL) for 
12 hours. (A) QUE-NL induces dose-dependent apoptosis and necrosis in C6 glioma cells. Cells were stained with Annexin V-FITC and analyzed by flow cytometry. (B) 
C6 glioma cells were treated with QUE for 12 hours. Cells were stained with Annexin V-FITC and analyzed by flow cytometry. (C) Control cells, including blank, DMSO, 
blank nanoliposome. (D) C6 glioma cells were stained with hematoxylin to detect the necrosis and cell apoptotic chromatin condensation. More than one field in each group 
were observed by fluorescence microscopy (400×), and representative images are shown. (E) Dose-dependent apoptosis and necrosis of C6 glioma cells by hematoxylin. 
Notes: Representative measurements of at least three independent experiments are shown. The values of cell death (apoptosis and necrosis) reported represent the 
mean ± standard deviation of three separate experiments. *P , 0.05; **P , 0.01; ***P , 0.001 compared with control cells. 
Abbreviations: DMSO, dimethylsulfoxide; NAC, N-acetylcysteine; QUE, quercetin; QUE-NL, nanoliposomes. Area of D2 means the normal mitochondrial membrane 
potential of C6 glioma cells, Area of D4 means the decreased mitochondrial membrane potential normal of C6 glioma cells.
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Figure 4 Necrosis of C6 glioma cells is involved in mediating ROS accumulation induced by QUE-NL. C6 glioma cells were treated with the indicated concentration of NL 
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regulators of necrotic cell death are already in early-phase 
clinical trials.22
Several studies have also shown that certain types 
of cell death share both apoptotic and necrotic mecha-
nisms in a process newly termed “necrapoptosis”.23,24 
QUE-NL induces morphological necrotic changes in 
cells and decreases cell viability in a dose-dependent and 
  time-dependent manner. These studies have also shown 
the existence of several   common points in the necrotic 
and apoptotic pathway, indicating that the signaling cross 
point is modulated. Therefore, the mode of cell death can 
be switched from apoptosis to programmed necrosis and 
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vice versa, which further supports the idea that necrosis 
is programmed and controllable.
QUE-NL can induce cell death which may not involve 
apoptosis. Therefore, we investigated the induction of cell 
death in C6 glioma cells after exposure to QUE-NL. The 
results of this study indicate that QUE-NL induced necrotic 
cell death not only by decreasing the ∆Ψm, but also by 
  promoting reactive oxygen species. QUE-NL-induced 
changes in ∆Ψm and cytochrome C release had no effects 
on caspase activation, but a reduction in ATP levels and 
increased lactate dehydrogenase activity indicates that 
QUE-NL stimulated necrotic cell death (Figure 7).
Quercetin is usually considered to be an excellent free 
radical scavenging antioxidant because of the high number of 
hydroxyl groups and conjugated orbitals via which quercetin 
can donate electrons or hydrogen ions, as well as scavenge 
H2O2 and superoxide anions.25 This is possible because QUE 
has both antioxidant and pro-oxidant properties. In the pres-
ence of a low glutathione content, oxidized quercetin reacts 
with protein thiols, exerting a toxic effect on cells.26,27 Simi-
larly, longer exposure to quercetin along with a high quercetin 
concentration causes a reduction in glutathione content, sug-
gesting the inability of quercetin to decrease reactive oxygen 
species for that period. As a consequence, the pro-oxidant 
effect of quercetin could prevail over the antioxidant effect and 
result in cell death by damaging cellular compartments.28,29
In this study, QUE-NL induced nonapoptotic cell death 
(necrosis) rather than apoptosis. In addition, caspase-3 activa-
tion did not differ between the control and QUE-NL-treated 
groups. Caspase-3 activation is an important contributor to 
apoptosis.30–32 QUE-NL did not alter the levels of proteins 
associated with apoptosis. Furthermore, reactive oxygen spe-
cies production can cause cell death, including involvement 
of necrosis.33,34 QUE-NL increased reactive oxygen species 
levels and decreased ∆Ψm levels. QUE-NL-induced reac-
tive oxygen species generation was reduced after pretreatment 
with N-acetylcysteine which increased the percentage of via-
ble cells, suggesting that QUE-NL-induced necrotic cell death 
is associated with production of reactive oxygen species.
Summary
All these results indicate that QUE-NL may have enhanced 
quercetin solubility, with improved bioactivity for inhibiting 
tumors, and its anticancer effect may be the result of long 
exposure to C6 glioma cells along with a high quercetin 
concentration causing a reduction in glutathione content and 
quercetin to accumulate a high reactive oxygen   species level 
for that period. Thus, the pro-oxidant effect of quercetin could 
prevail over the antioxidant effect and result in cell death. Cell 
death due to necrosis is associated with decreases in ∆Ψm35,36 
and ATP levels,37 and we observed that QUE-NL did indeed 
reduce ∆Ψm and ATP levels. It has been shown that necrotic 
cell death involved the release of lactate dehydrogenase.38 In 
the present study, QUE-NL increased lactate dehydrogenase 
levels. Our findings are in agreement with other reports37 
showing production of reactive oxygen   species, loss of 
∆Ψm, and ATP depletion in cancer cells, and that those cells 
undergo type III (necrotic) programmed cell death. In sum-
mary, QUE-NL is shown to be a new agent for targeted glioma 
treatment because it induces necrotic cell death, so may have 
an application as a new anticancer drug candidate.
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